about
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel diseaseGenome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociGenome-wide association identifies multiple ulcerative colitis susceptibility lociMeta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Molecular analysis of the gut microbiota of identical twins with Crohn's disease.IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac diseaseMetabolomics reveals metabolic biomarkers of Crohn's diseaseMultiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1).Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's diseaseCD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in miceDNA methylation profiles in monozygotic and dizygotic twins.Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's Disease.Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel diseaseA Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studiesLong-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.Dynamics of the human gut microbiome in inflammatory bowel disease.The history of genetics in inflammatory bowel disease.HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: a population-based retrospective study.A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.Letter: the impact of smoking on clinical outcomes after endoscopic dilatation in Crohn's disease - authors' reply.Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study.Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.No association between the eczema genes COL29A1 and IL31 and inflammatory bowel disease.Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome.Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.Birth weight, sex, and celiac disease: a nationwide twin study.Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients.Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.Editorial: do thiopurines and biologics decrease the risk of colectomy? Authors' reply.Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population.
P50
Q24601772-607930E8-1AD3-4A14-B09C-2965C03C221AQ24618592-6E358D8D-B251-419E-83C0-7202B25E3C61Q27865246-5A734911-9EB0-4E39-AB0B-97A841CF4139Q28943305-0B66B4B3-DE31-42D2-A57A-27519A1DA083Q33327494-F98A3F89-894E-4B26-A92F-A5EEBC87D4D7Q33403660-34BFDC0C-5E5C-4462-A062-E872E1B184F7Q33487783-FDB0BF0D-9098-4824-8151-63523704F4C1Q34117658-7BD29705-006D-463A-B42D-A76F33B683D2Q34499601-518E1B2A-792C-4A53-93FF-E73741717AF1Q34876558-EC3E89FB-68BA-4296-B488-634E143C7DB4Q34924376-E03F2A93-11BA-4E27-980D-B1DE8893ACEDQ34974051-2460B1D2-572B-4871-8BCD-5F9625C3B702Q34998273-8E16137B-C16D-46E2-8B2F-068BC826E589Q35597688-AE275637-EB4E-40A8-A6A2-3CAB500838F8Q36095561-1ED1F204-B954-4018-BFCC-AB5F5CEEEBB1Q36175033-3CB0A550-FBE1-42C7-B5CA-F639A5A99D55Q36429822-ED70CF5D-30C6-4F9C-B9A6-5CB1FF0B36A6Q37120315-FB53D824-2FA5-4242-9745-749DC19E32A3Q40186230-9CCD4D03-764F-4147-94E9-F5DCC85B2A21Q40338595-23741E49-D92B-48C2-8BD1-747E4C848E45Q42689162-9A61F932-CE07-466F-A4AF-962D3F242F6EQ42704205-42EC52BA-26D1-4DCC-9D53-22A73CA85B95Q42844389-76F3AEB1-E583-4E9C-832F-037459D3F720Q43793298-F470C627-CF6E-4192-86D8-A13CC35D548BQ43883077-5E62CCD0-2195-4151-AEAD-1FAE5FA313BEQ44121196-85671030-03A5-46DD-9A40-4695472DC0C0Q44295532-50A34B10-71C8-42D0-B082-41790F31D529Q44332424-1FE23026-8FC0-446E-B6F2-083C33D75802Q45162885-0A7FBEB2-C099-4DCB-93F6-572DE09C4859Q45841556-7E457099-EFD7-45D8-A5E6-31F4EE0899F5Q45905337-E58933E1-435E-4A50-B64C-5DBA81BF1085Q46130626-F6D896B6-A978-4D9D-9CE3-9D470222DE42Q46875109-FE335E97-3DD7-4A21-9B06-5CA5F9A59267Q47158803-A8308E85-D02D-4B26-B18E-EF70D43CAA1FQ47658760-835B01AE-CE32-4F92-BADA-02B657F49DC3Q47744754-7D02AAEE-0182-4870-AFDE-3E85F371C64FQ47754136-EC66B6A9-C018-4D5F-B31B-399FBA929931Q48085176-43FD7FC6-9B7B-46D5-9BE3-0721ED70E508Q48201404-0B1BCF69-71F2-423E-85B6-9C2E0A4DADF6Q50544354-A963F34D-1617-437D-B432-05EF85DC8B32
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jonas Halfvarson
@ast
Jonas Halfvarson
@en
Jonas Halfvarson
@es
Jonas Halfvarson
@nl
Jonas Halfvarson
@sl
type
label
Jonas Halfvarson
@ast
Jonas Halfvarson
@en
Jonas Halfvarson
@es
Jonas Halfvarson
@nl
Jonas Halfvarson
@sl
prefLabel
Jonas Halfvarson
@ast
Jonas Halfvarson
@en
Jonas Halfvarson
@es
Jonas Halfvarson
@nl
Jonas Halfvarson
@sl
P214
P906
P106
P21
P213
0000 0000 5383 5467
P214
P31
P496
0000-0003-0122-7234
P569
1970-01-01T00:00:00Z
P735
P7859
viaf-41819707